Logo image of DWAC

DIGITAL WORLD ACQUISITION-A (DWAC) Stock Fundamental Analysis

NASDAQ:DWAC - Nasdaq - US25400Q1058 - Common Stock - Currency: USD

49.95  +13.01 (+35.22%)

After market: 53.75 +3.8 (+7.61%)

Fundamental Rating

1

Overall DWAC gets a fundamental rating of 1 out of 10. We evaluated DWAC against 0 industry peers in the Unkown industry. DWAC may be in some trouble as it scores bad on both profitability and health. DWAC has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year DWAC has reported negative net income.
In the past year DWAC has reported a negative cash flow from operations.
DWAC Yearly Net Income VS EBIT VS OCF VS FCFDWAC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 -5M -10M -15M

1.2 Ratios

Industry RankSector Rank
ROA -8.12%
ROE -10.22%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
DWAC Yearly ROA, ROE, ROICDWAC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 -1 -2 -3 -4 -5

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for DWAC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
DWAC Yearly Profit, Operating, Gross MarginsDWAC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022

More info and screens

2

2. Health

2.1 Basic Checks

The number of shares outstanding for DWAC remains at a similar level compared to 1 year ago.
DWAC has a worse debt/assets ratio than last year.
DWAC Yearly Shares OutstandingDWAC Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 10M 20M 30M
DWAC Yearly Total Debt VS Total AssetsDWAC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 100M 200M 300M

2.2 Solvency

DWAC has an Altman-Z score of 16.62. This indicates that DWAC is financially healthy and has little risk of bankruptcy at the moment.
DWAC has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z 16.62
ROIC/WACCN/A
WACCN/A
DWAC Yearly LT Debt VS Equity VS FCFDWAC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 0 50M 100M 150M 200M 250M

2.3 Liquidity

DWAC has a Current Ratio of 0.06. This is a bad value and indicates that DWAC is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.06 indicates that DWAC may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.06
Quick Ratio 0.06
DWAC Yearly Current Assets VS Current LiabilitesDWAC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 5M 10M 15M 20M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for DWAC have decreased strongly by -133.74% in the last year.
EPS 1Y (TTM)-133.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-227.86%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for DWAC. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DWAC Price Earnings VS Forward Price EarningsDWAC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DWAC Per share dataDWAC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for DWAC!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DIGITAL WORLD ACQUISITION-A

NASDAQ:DWAC (3/25/2024, 8:19:28 PM)

After market: 53.75 +3.8 (+7.61%)

49.95

+13.01 (+35.22%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners46.25%
Inst Owner Change0.77%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap0
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 7.53
P/tB 7.53
EV/EBITDA N/A
EPS(TTM)-0.68
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.06
OCFYN/A
SpS0
BVpS6.63
TBVpS6.63
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.12%
ROE -10.22%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.06
Quick Ratio 0.06
Altman-Z 16.62
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-133.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-227.86%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-182.28%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-24.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-24.32%
OCF growth 3YN/A
OCF growth 5YN/A